Bills › 91st General Assembly
Relating to insurance coverage for prescription insulin drugs
Sponsored by Sen. Liz Bennett (D), Sen. Tony Bisignano (D), Sen. Matt Blake (D), Sen. Molly Donahue (D), Sen. William A. Dotzler Jr. (D), Sen. Catelin Drey (D), Sen. Sarah Trone Garriott (D), Sen. Renee Hardman (D), Sen. Izaah Knox (D), Sen. Janet Petersen (D), Sen. Herman C. Quirmbach (D), Sen. Art Staed (D), Sen. Thomas Townsend (D), Sen. Janice Weiner (D), Sen. Cindy Winckler (D), Sen. Mike Zimmer (D)
Where it is now
- Done: IntroducedJanuary 14, 2026
- Done: SubcommitteeJanuary 22, 2026
- Stopped: Senate committeeDied when the General Assembly ended
- Next: Passes the Senate
- Next: House committeeFunnel: by March 20, 2026
- Next: Passes the House
- Next: To the Governor
- Next: Signed into law
Died when the session ended The 2026 session adjourned on May 3, 2026, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?
What’s in it
AI summary Health insurance plans in Iowa would be required to limit how much people pay out-of-pocket for certain types of insulin. For a supply of up to 31 days, the cost-sharing amount for these insulin drugs cannot be more than $25. This rule applies to various types of insulin used to treat diabetes, such as rapid-acting or long-acting versions.1
Read the official explanation
This bill relates to prescription insulin drugs and coverage by policies, contracts, or plans providing for third-party payment or prepayment of health or medical expenses that provide coverage for prescription drugs. The bill requires a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses that provides coverage for prescription drugs to cap the total amount of cost-sharing that a covered person is required to pay per prescription filled of an insulin drug to an amount not more than $25 for an up to 31-day supply of at least one type of rapid-acting prescription insulin drugs, short-acting prescription insulin drugs, intermediate-acting prescription insulin drugs, or long-acting prescription insulin drugs. “Prescription insulin drug” is defined in the bill as a prescription drug that contains insulin, is used to treat diabetes, has been prescribed as medically necessary by a covered person’s health care professional, and is a benefit covered by a covered person’s policy, contract, or plan. The bill defines “cost-sharing” as any coverage limit, copayment, coinsurance, deductible, or other out-of-pocket expense imposed on a covered person. The bill does not prohibit a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses from reducing a covered person’s cost-sharing to less than $25 for up to a 31-day supply of a prescription insulin drug. The bill applies to third-party payment provider contracts, policies, or plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2027, by the third-party payment providers enumerated in the bill. The bill specifies the types of specialized health-related insurance which are not subject to the coverage requirements of the bill. The commissioner of insurance may adopt rules to administer the requirements of the bill.
Senate subcommittee
Named January 22, 2026. It hasn’t reported yet.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
1 written public comment to its subcommittee: February 5, 2026 (1) · on the Legislature’s site
Family tree
Tried before
91st General Assembly
Earlier and later bills are matched by wording or an identical title.
Tried before
This idea has been filed in 3 earlier General Assemblies. None became law, though one got through a chamber.
- HF 502 Relating to insurance coverage for prescription insulin drugs90th General Assembly · In committee · same titleCleared committee
- HF 694 Relating to insurance coverage for prescription insulin drugs90th General Assembly · In committee · same titleCleared committee
- SF 2062 Relating to insurance coverage for prescription insulin drugs90th General Assembly · In committee · same titleCleared committee
- SF 2214 Relating to insurance coverage for prescription insulin drugs90th General Assembly · Approved by committee · nearly identicalCleared committee
- HF 263 Relating to insurance coverage for prescription insulin drugs, and including applicability…89th General Assembly · Passed House · nearly identicalPassed a chamber
- HF 2511 Relating to prescription refills in emergency situations and insurance coverage for prescr…89th General Assembly · In committee · similarCleared committee
- HF 2138 Relating to insurance coverage for prescription insulin drugs88th General Assembly · Passed House · same titlePassed a chamber
- SF 2113 Relating to insurance coverage for prescription insulin drugs88th General Assembly · In committee · same titleCleared committee
Similar bills this General Assembly
- HF 405 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeNearly identical
- HF 658 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeNearly identical
- SF 2322 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeNearly identical
Matched by wording or an identical title.